Usefulness of diffusion-weighted imaging in the evaluation of renal masses.

OBJECTIVE The objective of our study was to assess the value of diffusion-weighted imaging in differentiating among the various subgroups of renal masses. MATERIALS AND METHODS This retrospective study measured the apparent diffusion coefficients (ADCs) of renal masses. Malignant lesions were confirmed with surgical pathology results. Benign cystic lesions were stable without treatment for a minimum follow-up of 24 months. RESULTS There were 20 and 22 patients, respectively, with benign lesions (three abscess, 31 cysts) and malignant lesions (17 clear cell, five papillary, one chromophobe, and two transitional cell cancers). The malignant lesions were larger than the benign lesions (mean diameter, 4.2 vs 2.6 cm, respectively; p = 0.01, Student's t test). The ADC values of the benign lesions were significantly higher than those of the malignant lesions (mean, 2.72 vs 1.88 x 10(-3) mm(2)/s; p < 0.0001). The ADCs of the 31 benign cysts were significantly higher than those of the seven cystic renal cancers (2.77 vs 2.02 x 10(-3) mm(2)/s; p < 0.001). There was no significant difference between the ADCs of clear cell cancers and non-clear cell cancers (1.85 vs 1.97 x 10(-3) mm(2)/s; p = 0.18), but an ADC of less than 1.79 x 10(-3) mm(2)/s was seen only with clear cell cancer. The ADCs of high-grade clear cell cancers (Fuhrman grades III and IV) tended to be lower than those of low-grade clear cell cancers (1.77 vs 1.95 x 10(-3) mm(2)/s; p = 0.12). Among the clear cell cancers, an ADC value of greater than 2.12 x 10(-3) mm(2)/s was seen only with low-grade histology. For differentiating benign from malignant lesions, receiver operating characteristic (ROC) analysis showed an area under the ROC curve of 0.989 (95% CI, 0.919-0.996; p < 0.0001). CONCLUSION ADC measurements may aid in differentiating among the various subgroups of renal masses, particularly benign cystic lesions from cystic renal cell cancers.

[1]  A. Levy Diffusion-Weighted MR Imaging of Kidneys in Healthy Volunteers and Patients With Parenchymal Diseases: Initial Experience , 2006 .

[2]  D. Collins,et al.  Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. , 2011, Radiology.

[3]  Juergen Hennig,et al.  Quantitative diffusion tensor MR imaging of the brain: field strength related variance of apparent diffusion coefficient (ADC) and fractional anisotropy (FA) scalars , 2006, European Radiology.

[4]  M. Kattan,et al.  Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. , 2002, Urology.

[5]  A. Ruppert-Kohlmayr,et al.  Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. , 2004, AJR. American journal of roentgenology.

[6]  R. Agid,et al.  ORIGINAL RESEARCH Preoperative Grading of Presumptive Low-Grade Astrocytomas on MR Imaging: Diagnostic Value of Minimum Apparent Diffusion Coefficient , 2008 .

[7]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[8]  N. Lawrentschuk,et al.  Imaging renal cell carcinoma with ultrasonography, CT and MRI , 2010, Nature Reviews Urology.

[9]  R. Uzzo,et al.  Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. , 2008, The Journal of urology.

[10]  M. Yanagawa,et al.  Imaging characteristics of papillary renal cell carcinoma by computed tomography scan and magnetic resonance imaging , 2005, International journal of urology : official journal of the Japanese Urological Association.

[11]  Jean-Luc Daire,et al.  Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. , 2003, Radiology.

[12]  C. Ganter,et al.  Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique , 2008, European Radiology.

[13]  K. Scheffler,et al.  Assessing extracranial tumors using diffusion-weighted whole-body MRI. , 2011, Zeitschrift fur medizinische Physik.

[14]  C. Calli,et al.  Minimum apparent diffusion coefficients in the evaluation of brain tumors. , 2005, European journal of radiology.

[15]  Haiyi Wang,et al.  Applications of diffusion-weighted magnetic resonance imaging in renal cell carcinoma , 2011, Expert review of anticancer therapy.

[16]  E. Yıldırım,et al.  The effect of hypertension on the apparent diffusion coefficient values of kidneys. , 2008, Diagnostic and interventional radiology.

[17]  Gary Liney,et al.  Correlation of diffusion‐weighted magnetic resonance data with cellularity in prostate cancer , 2009, BJU international.

[18]  G. Einarsson,et al.  Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. , 2005, European urology.

[19]  A. Razek,et al.  Role of Diffusion-Weighted Magnetic Resonance Imaging in Characterization of Renal Tumors , 2011, Journal of computer assisted tomography.

[20]  Martijn R. Meijerink,et al.  Targeted therapies in renal cell cancer: recent developments in imaging , 2010, Targeted Oncology.

[21]  Toshinori Hirai,et al.  Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.

[22]  Roberto Miano,et al.  Correlation of diffusion-weighted MR imaging with cellularity of renal tumours. , 2004, Anticancer research.

[23]  S. Madersbacher,et al.  Elective open nephron-sparing surgery for renal masses: single-center experience with 129 consecutive patients. , 2004, Urology.

[24]  S. Higano,et al.  Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas , 2009, Neurological research.

[25]  Danny C. Kim,et al.  Advanced Renal Mass Imaging: Diffusion and Perfusion MRI , 2012, Current Urology Reports.

[26]  J. Patard,et al.  Lymph node dissection in renal cell carcinoma. , 2011, European urology.

[27]  Armen Khararjian,et al.  Effect of intravenous extracellular gadolinium based contrast medium on renal diffusion weighted images. , 2011, Academic radiology.

[28]  Hersh Chandarana,et al.  Comparison of Biexponential and Monoexponential Model of Diffusion Weighted Imaging in Evaluation of Renal Lesions: Preliminary Experience , 2010, Investigative radiology.

[29]  R. Agid,et al.  Preoperative Grading of Presumptive Low-Grade Astrocytomas on MR Imaging: Diagnostic Value of Minimum Apparent Diffusion Coefficient , 2008, American Journal of Neuroradiology.

[30]  M. Gordon Efficacy of Sunitinib and Sorafenib in Metastatic Papillary and Chromophobe Renal Cell Carcinoma , 2009 .

[31]  P. Ramchandani,et al.  Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. , 2006, Urology.

[32]  K. Kono,et al.  The role of diffusion-weighted imaging in patients with brain tumors. , 2001, AJNR. American journal of neuroradiology.

[33]  Ivan Pedrosa,et al.  Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings. , 2009, Radiology.

[34]  M. Kattan,et al.  Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. , 2006, The Journal of urology.

[35]  Ahmed Mosbah,et al.  Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. , 2005, The Journal of urology.

[36]  Hedvig Hricak,et al.  Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience. , 2008, Radiology.

[37]  Kei Yamada,et al.  Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. , 2008, Radiology.

[38]  P. Ramchandani,et al.  Renal Imaging in Patients with Renal Impairment , 2011, Current urology reports.

[39]  Xiaoying Wang,et al.  Relationship between the renal apparent diffusion coefficient and glomerular filtration rate: Preliminary experience , 2007, Journal of magnetic resonance imaging : JMRI.

[40]  Qun Chen,et al.  Optimization of b‐value sampling for diffusion‐weighted imaging of the kidney , 2012, Magnetic resonance in medicine.

[41]  H. Thoeny,et al.  Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature. , 2012, European urology.

[42]  S. Pahernik,et al.  Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. , 2006, The Journal of urology.

[43]  M. Bosniak,et al.  The current radiological approach to renal cysts. , 1986, Radiology.

[44]  Bachir Taouli,et al.  Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. , 2009, Radiology.

[45]  Mahul B. Amin,et al.  Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial Neoplasms: An Experience of 405 Cases , 2002, The American journal of surgical pathology.

[46]  C. Siegel Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. , 2005, The Journal of urology.

[47]  F Stacul,et al.  Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results. , 2004, The British journal of radiology.

[48]  Shigeru Nawano,et al.  Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. , 2004, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[49]  M. Johannsen,et al.  Difference between clinical and pathologic renal tumor size, correlation with survival, and implications for patient counseling regarding nephron-sparing surgery. , 2011, AJR. American journal of roentgenology.

[50]  F. Akisik,et al.  Diffusion-weighted imaging in characterization of cystic pancreatic lesions. , 2011, Clinical radiology.

[51]  N. Rofsky,et al.  MR classification of renal masses with pathologic correlation , 2008, European Radiology.

[52]  P. Olbert,et al.  Metastatic non‐clear cell renal cell carcinoma: current therapeutic options , 2008, BJU international.

[53]  T. Hirai,et al.  Magnetic resonance imaging of pilocytic astrocytomas: usefulness of the minimum apparent diffusion coefficient (adc) value for differentiation from high-grade gliomas , 2008, Acta radiologica.

[54]  T. Sakurai,et al.  Usefulness of diffusion-weighted imaging of breast tumors: quantitative and visual assessment , 2011, Japanese Journal of Radiology.

[55]  R. Oyen,et al.  Diffusion-weighted MR imaging in the evaluation of renal infection: preliminary results. , 2002, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.

[56]  S. Luk,et al.  MR diffusion-weighted imaging of kidney: differentiation between hydronephrosis and pyonephrosis. , 2001, Clinical imaging.

[57]  R C McKinstry,et al.  Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. , 2001, AJR. American journal of roentgenology.

[58]  P. Humphrey,et al.  Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[59]  S. F. Carbone,et al.  Diffusion-weighted magnetic resonance imaging in the evaluation of renal function: A preliminary study , 2007, La radiologia medica.

[60]  F. Aigner,et al.  Assessment and characterisation of common renal masses with CT and MRI , 2011, Insights into imaging.